Cargando…

Regulating drug promotion to promote the public health: a response to Bennett et al.

Detalles Bibliográficos
Autor principal:	Zettler, Patricia J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034385/ https://www.ncbi.nlm.nih.gov/pubmed/27774220 http://dx.doi.org/10.1093/jlb/lsv050

Ejemplares similares

Modernizing biomedical regulation: foresight and values in the promotion of responsible research and innovation
por: Harmon, Shawn H.E.
Publicado: (2016)

Is it ‘gene therapy’?
por: Sherkow, Jacob S, et al.
Publicado: (2018)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

The process of designing for [online] learning: response to Bennett et al.
por: Lee, Dabae
Publicado: (2021)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Assessing health-state utility: is there a uniquely privileged perspective?
por: Wasserman, David
Publicado: (2020)

Bias adjustment and the nature of health-state utility
por: Menzel, Paul T
Publicado: (2020)

We should not vaccinate the young to protect the old: a response to Giubilini, Savulescu, and Wilkinson
por: de Miguel Beriain, Iñigo
Publicado: (2021)

Drinking from the Data Well: Response to Gamete donor anonymity and limits on numbers of offspring: the views of three stakeholders
por: Ertman, Martha M.
Publicado: (2016)

Designing for emergency remote blended and online education: a response to Bennett et al. (2017)
por: Connolly, Cornelia, et al.
Publicado: (2020)

Law and neuroscience: recommendations submitted to the President's Bioethics Commission
por: Jones, Owen D., et al.
Publicado: (2014)

It depends whose data are being shared: considerations for genomic data sharing policies
por: Robinson, Jill O., et al.
Publicado: (2015)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Uterus transplantation: does procreative liberty encompass a right to gestate?
por: Alghrani, Amel
Publicado: (2016)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

‘No, actually your life is going considerably worse’: a comment on Nir Eyal
por: Enoch, David
Publicado: (2020)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Reporting, recording, and communication of COVID-19 cases in workplace: data protection as a moving target
por: Shabani, Mahsa, et al.
Publicado: (2020)

The value of qualitative methods to public health research, policy and practice
por: Stickley, T, et al.
Publicado: (2022)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

‘Good soldiers are made, not born’(⊥): the dangers of medicalizing ability in the military use of genetics
por: Roberts, Jessica L.
Publicado: (2015)

The most plausible pro-coercion view: requiring informed agreement while penalizing non-participation in research
por: Barnhill, Anne
Publicado: (2015)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Diversion effects, incentive effects, and the goals of research ethics promulgations
por: Wenner, Danielle M.
Publicado: (2015)

The problems of liminal states, line drawing, and false dichotomies
por: Suter, Sonia
Publicado: (2015)

The mouse that trolled
por: Hardy, John
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qd4gl6rh4u6uf6s6faokfed46s